Funders › RI › Dr Ralph & Marian Falk Medical Research TR › 2023
Grants paid by Dr Ralph & Marian Falk Medical Research TR, tax year 2023
EIN 36-6975534 · Dallas, RI · Form 990-PF, Part XV
In tax year 2023, Dr Ralph & Marian Falk Medical Research TR (EIN 36-6975534) reported 46 grants paid totaling $8,040,793. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2023
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2023 | Brown University of Providence Providence, RI | C | $504,854 | paid | ANTI-MALARIA DRUGS TARGETNG | 202410899349100531 |
| 2023 | Indiana University Bloomington, IN | C | $445,923 | paid | TARGETING PEANUT-SPECIFIC | 202410899349100531 |
| 2023 | Medical College of Wisconsin Sen Neuron Milwaukee, WI | C | $346,469 | paid | DEVELOPMENT OF SENSORY | 202410899349100531 |
| 2023 | Thomas Jefferson University Philadelphia, PA | B | $333,333 | paid | PROTACS FOR TARGETING BRCA | 202410899349100531 |
| 2023 | Northwestern University Evanstone, IL | B | $331,974 | paid | T CELL THEARPY FOR | 202410899349100531 |
| 2023 | Case Western Reserve University Cleveland, OH | U | $301,032 | paid | B CELL CANCER THERAPY USING | 202410899349100531 |
| 2023 | University of Cincinnati Cleveland, OH | U | $211,322 | paid | STUDIES FOR REPURPOSING | 202410899349100531 |
| 2023 | University of Cincinnati Cleveland, OH | U | $204,619 | paid | TARGETING SEXUAL CYCLE OF | 202410899349100531 |
| 2023 | Childrens Hospital Medical Center Cincinnati, OH | B | $200,000 | paid | LUPUS NEPHRITIS BIOMARKERS | 202410899349100531 |
| 2023 | Yale University School of Medicine New Haven, CT | U | $200,000 | paid | TARGETED DEGREDATION OF | 202410899349100531 |
| 2023 | Regents of University of Michigan Ann Arbor, MI | D | $200,000 | paid | DEVICE TO PREDICT | 202410899349100531 |
| 2023 | Cleveland Clinic Foundation Cleveland, OH | C | $200,000 | paid | NEW WEAPONS TO FIGHT | 202410899349100531 |
| 2023 | Thomas Jefferson University Philadelphia, PA | B | $196,613 | paid | CHEMOKINE ANTAGONIST FOR | 202410899349100531 |
| 2023 | Childrens Hospital Medical Center Cincinnati, OH | B | $190,000 | paid | DEVELOP HUMAN LIVER | 202410899349100531 |
| 2023 | Stanford University - Development Services Redwood City, CA | U | $190,000 | paid | NOVEL THERAPIES - MAJOR | 202410899349100531 |
| 2023 | Board Regents of University of Wisconsin Milwaukee, WI | U | $190,000 | paid | NANOPARTICLES TARGET | 202410899349100531 |
| 2023 | Yale University School of Medicine New Haven, CT | U | $175,188 | paid | DEVELOP PHAGE THERAPY TO | 202410899349100531 |
| 2023 | Board Regents of University of Wisconsin Milwaukee, WI | U | $175,000 | paid | DIABETES STEM CELL CURE - | 202410899349100531 |
| 2023 | University of Chicago Chicago, IL | C | $175,000 | paid | DEVELOPMENT OF SYNGAP1 | 202410899349100531 |
| 2023 | Case Western Reserve University Cleveland, OH | U | $175,000 | paid | BLOCKING PEPTIDE TREATMENT | 202410899349100531 |
| 2023 | Washington University St Louis, MO | B | $174,784 | paid | ZIKA VIRUS GENETIC ARMING- | 202410899349100531 |
| 2023 | Stanford University - Development Services Redwood City, CA | U | $173,785 | paid | METABOLIC PAUSING - ORGAN | 202410899349100531 |
| 2023 | Indiana University Bloomington, IN | C | $172,729 | paid | NOVEL MINIMALLY INVASIVE | 202410899349100531 |
| 2023 | Rehabilitation Institute of Chicago Chicago, IL | B | $171,431 | paid | REPURPOSE 5-AZACYTIDINE - | 202410899349100531 |
| 2023 | Mayo Clinic Minneapolis, MN | U | $168,095 | paid | IN VIVO GENERATION - CAR T | 202410899349100531 |
| 2023 | Stanford University - Development Services Redwood City, CA | U | $159,101 | paid | NOVEL DNA-GUIDED ARGONAUTE | 202410899349100531 |
| 2023 | State University of Iowa Iowa City, IA | D | $156,013 | paid | IMPROVE HYPOXIC TUMOR MGMT | 202410899349100531 |
| 2023 | University of Chicago Chicago, IL | C | $148,325 | paid | TUMOR ANUEPLOIDY - | 202410899349100531 |
| 2023 | University of Minnesota Minneapolis, MN | U | $114,914 | paid | AEROSOLIZED THYROID HORMONE | 202410899349100531 |
| 2023 | Yale University School of Medicine New Haven, CT | U | $100,000 | paid | BEDSIDE LIQUID BIOPSY FOR | 202410899349100531 |
| 2023 | Kumc Research Institute Kansas City, KS | B | $100,000 | paid | EULICIDATING ROLES RELATED | 202410899349100531 |
| 2023 | University of Minnesota Minneapolis, MN | U | $100,000 | paid | ELECTRICAL BRAIN CIRCUIT | 202410899349100531 |
| 2023 | Stanford University - Development Services Redwood City, CA | U | $100,000 | paid | BIOMARKERS FOR IMMUNE | 202410899349100531 |
| 2023 | Yale University School of Medicine New Haven, CT | U | $100,000 | paid | DEVELOP ANTIGEN-MIMICRY | 202410899349100531 |
| 2023 | University of Chicago Chicago, IL | C | $100,000 | paid | STATISTICAL DESIGN OF | 202410899349100531 |
| 2023 | Cleveland Clinic Foundation Cleveland, OH | C | $100,000 | paid | GLIOBLASTOMA ANTI-CANCER | 202410899349100531 |
| 2023 | Michigan State University East Lansing, MI | U | $100,000 | paid | MMPL3 INHIBITORS - | 202410899349100531 |
| 2023 | Childrens Hospital Medical Center Cincinnati, OH | B | $100,000 | paid | EARLY OUTCOME INDICATORS | 202410899349100531 |
| 2023 | Northwestern University Evanstone, IL | B | $100,000 | paid | NEOANTIGEN INDUCERS AS | 202410899349100531 |
| 2023 | Regents of University of Michigan Ann Arbor, MI | D | $100,000 | paid | DECODING THE DRUGGABLE | 202410899349100531 |
| 2023 | Cleveland Clinic Foundation Cleveland, OH | C | $99,684 | paid | DEVELOPMENT OF NEW DRUG FOR | 202410899349100531 |
| 2023 | Rush University Medical Center Chicago, IL | B | $99,458 | paid | ANTI-HIV ANTIBODIES TO | 202410899349100531 |
| 2023 | University of Iowa Research Foundation Iowa City, IA | B | $94,489 | paid | PIEZOELECTRIC IMMUNOSENSOR | 202410899349100531 |
| 2023 | Ohio State University Columbus, OH | U | $94,051 | paid | OPTIMIZING BTK INHIBITOR | 202410899349100531 |
| 2023 | Case Western Reserve University Cleveland, OH | U | $93,494 | paid | IMMUNOTHERAPY FOR B CELL | 202410899349100531 |
| 2023 | Medical College of Wisconsin Milwaukee, WI | B | $74,113 | paid | NEW DRUGS TO TREAT | 202410899349100531 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990-PF e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.